Fms-Living Center is a medicare approved dialysis facility center in Fairport, New York and it has 4 dialysis stations. It is located in Monroe county at 6687 Pittsford Palmyra Road, Ste 38, Fairport, NY, 14450. You can reach out to the office of Fms-Living Center at (585) 421-9839. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fms-Living Center has the following ownership type - Profit. It was first certified by medicare in May, 2002. The medicare id for this facility is 332630 and it accepts patients under medicare ESRD program.
| Name | Fms-Living Center |
|---|---|
| Location | 6687 Pittsford Palmyra Road, Ste 38, Fairport, New York |
| No. of Dialysis Stations | 4 |
| Medicare ID | 332630 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 6687 Pittsford Palmyra Road, Ste 38, Fairport, New York, 14450 | |
| (585) 421-9839 | |
| Not Available |
News Archive
DP Medical Ltd has secured a deal with Sheffield Teaching Hospitals NHS Foundation Trust to become the first NHS Trust in the country to adopt ZedScan as part of its cervical cancer care pathway.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new report called ‘F as in Fat: How Obesity Threatens America's Future 2011' from the Trust for America's Health and the Robert Wood Johnson Foundation, shows that Massachusetts has one of the lowest obesity rates in the nation even as obesity rises across the Bay State.
Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 4 |
News Archive
DP Medical Ltd has secured a deal with Sheffield Teaching Hospitals NHS Foundation Trust to become the first NHS Trust in the country to adopt ZedScan as part of its cervical cancer care pathway.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new report called ‘F as in Fat: How Obesity Threatens America's Future 2011' from the Trust for America's Health and the Robert Wood Johnson Foundation, shows that Massachusetts has one of the lowest obesity rates in the nation even as obesity rises across the Bay State.
Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 8 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 29 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
DP Medical Ltd has secured a deal with Sheffield Teaching Hospitals NHS Foundation Trust to become the first NHS Trust in the country to adopt ZedScan as part of its cervical cancer care pathway.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new report called ‘F as in Fat: How Obesity Threatens America's Future 2011' from the Trust for America's Health and the Robert Wood Johnson Foundation, shows that Massachusetts has one of the lowest obesity rates in the nation even as obesity rises across the Bay State.
Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fms-Living Center with elevated calcium levels.
| Patients with hypercalcemia | 9 |
| Hypercalcemia patient months | 38 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 12 |
| Patients with Serumphosphor less than 3.5 mg/dL | 29 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 24 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 4 |
News Archive
DP Medical Ltd has secured a deal with Sheffield Teaching Hospitals NHS Foundation Trust to become the first NHS Trust in the country to adopt ZedScan as part of its cervical cancer care pathway.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new report called ‘F as in Fat: How Obesity Threatens America's Future 2011' from the Trust for America's Health and the Robert Wood Johnson Foundation, shows that Massachusetts has one of the lowest obesity rates in the nation even as obesity rises across the Bay State.
Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 9 |
| Patient months included in arterial venous fistula and catheter summaries | 27 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
DP Medical Ltd has secured a deal with Sheffield Teaching Hospitals NHS Foundation Trust to become the first NHS Trust in the country to adopt ZedScan as part of its cervical cancer care pathway.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new report called ‘F as in Fat: How Obesity Threatens America's Future 2011' from the Trust for America's Health and the Robert Wood Johnson Foundation, shows that Massachusetts has one of the lowest obesity rates in the nation even as obesity rises across the Bay State.
Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 6 |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
DP Medical Ltd has secured a deal with Sheffield Teaching Hospitals NHS Foundation Trust to become the first NHS Trust in the country to adopt ZedScan as part of its cervical cancer care pathway.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
A new report called ‘F as in Fat: How Obesity Threatens America's Future 2011' from the Trust for America's Health and the Robert Wood Johnson Foundation, shows that Massachusetts has one of the lowest obesity rates in the nation even as obesity rises across the Bay State.
Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).
› Verified 2 days ago